TECOGEN INC/WALTHAM MA (TGEN) Fundamental Analysis & Valuation

NYSEARCA:TGEN • US87876P2011

Current stock price

4.29 USD
+0.12 (+2.88%)
At close:
4.21 USD
-0.08 (-1.86%)
After Hours:

This TGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TGEN Profitability Analysis

1.1 Basic Checks

  • In the past year TGEN has reported negative net income.
  • In the past year TGEN had a positive cash flow from operations.
  • TGEN had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: TGEN reported negative operating cash flow in multiple years.
TGEN Yearly Net Income VS EBIT VS OCF VS FCFTGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

  • TGEN's Return On Assets of -15.31% is on the low side compared to the rest of the industry. TGEN is outperformed by 82.93% of its industry peers.
  • Looking at the Return On Equity, with a value of -46.53%, TGEN is doing worse than 80.49% of the companies in the same industry.
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROIC N/A
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
TGEN Yearly ROA, ROE, ROICTGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • TGEN has a Gross Margin of 43.64%. This is amongst the best in the industry. TGEN outperforms 87.80% of its industry peers.
  • In the last couple of years the Gross Margin of TGEN has grown nicely.
  • TGEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
TGEN Yearly Profit, Operating, Gross MarginsTGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. TGEN Health Analysis

2.1 Basic Checks

  • TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for TGEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TGEN Yearly Shares OutstandingTGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
TGEN Yearly Total Debt VS Total AssetsTGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 2.01 indicates that TGEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.01, TGEN is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of TGEN is 0.63, which is an excellent value as it means it would take TGEN, only 0.63 years of fcf income to pay off all of its debts.
  • TGEN's Debt to FCF ratio of 0.63 is amongst the best of the industry. TGEN outperforms 90.24% of its industry peers.
  • TGEN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of TGEN (0.18) is better than 75.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Altman-Z 2.01
ROIC/WACCN/A
WACC10.27%
TGEN Yearly LT Debt VS Equity VS FCFTGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • TGEN has a Current Ratio of 1.32. This is a normal value and indicates that TGEN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of TGEN (1.32) is worse than 80.49% of its industry peers.
  • A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.74, TGEN is doing worse than 87.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.74
TGEN Yearly Current Assets VS Current LiabilitesTGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TGEN Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-12.47%

3.2 Future

  • TGEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.13% yearly.
  • TGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.14% yearly.
EPS Next Y6.23%
EPS Next 2Y59.86%
EPS Next 3Y55.65%
EPS Next 5Y36.13%
Revenue Next Year1.8%
Revenue Next 2Y51.69%
Revenue Next 3Y50.44%
Revenue Next 5Y34.14%

3.3 Evolution

TGEN Yearly Revenue VS EstimatesTGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
TGEN Yearly EPS VS EstimatesTGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. TGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TGEN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TGEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TGEN Price Earnings VS Forward Price EarningsTGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, TGEN is valued a bit more expensive than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.44
EV/EBITDA N/A
TGEN Per share dataTGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TGEN's earnings are expected to grow with 55.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.86%
EPS Next 3Y55.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TGEN Dividend Analysis

5.1 Amount

  • TGEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TGEN Fundamentals: All Metrics, Ratios and Statistics

TECOGEN INC/WALTHAM MA

NYSEARCA:TGEN (4/24/2026, 8:10:48 PM)

After market: 4.21 -0.08 (-1.86%)

4.29

+0.12 (+2.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-18
Earnings (Next)05-07
Inst Owners27.48%
Inst Owner Change-0.87%
Ins Owners23.05%
Ins Owner Change1.24%
Market Cap128.10M
Revenue(TTM)N/A
Net Income(TTM)-4.76M
Analysts82.86
Price Target7.4 (72.49%)
Short Float %5.71%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)-51.67%
PT rev (3m)-51.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.66
P/FCF 41.44
P/OCF 31.55
P/B 12.52
P/tB 23.85
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)0.1
FCFY2.41%
OCF(TTM)0.14
OCFY3.17%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.64%
FCFM 13.67%
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 175.01%
Cap/Sales 4.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.74
Altman-Z 2.01
F-Score4
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y6.23%
EPS Next 2Y59.86%
EPS Next 3Y55.65%
EPS Next 5Y36.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-12.47%
Revenue Next Year1.8%
Revenue Next 2Y51.69%
Revenue Next 3Y50.44%
Revenue Next 5Y34.14%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-61.05%
EBIT Next 3Y56.97%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A

TECOGEN INC/WALTHAM MA / TGEN Fundamental Analysis FAQ

What is the fundamental rating for TGEN stock?

ChartMill assigns a fundamental rating of 3 / 10 to TGEN.


What is the valuation status for TGEN stock?

ChartMill assigns a valuation rating of 1 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.


How profitable is TECOGEN INC/WALTHAM MA (TGEN) stock?

TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.


How financially healthy is TECOGEN INC/WALTHAM MA?

The financial health rating of TECOGEN INC/WALTHAM MA (TGEN) is 4 / 10.